Location and mapping of the human rostromedial tegmental nucleus and associated midbrain inhibitory nuclei regulating dopamine neurons.

Overview

1. Brain and Mind Centre, Faculty of Medicine and Health School of Medical Sciences, The University of Sydney,Sydney, NSW 2050 Australia
2. Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network,Chevy Chase, MD 20815 USA

Abstract

Animal experiments reveal distinct GABAergic cell clusters within the dopaminergic midbrain regions in the rostromedial tegmental nucleus (RMTg) and retrorubral fields (RRF) that have yet to be clearly defined in humans. These neurons send prominent inhibitory projections to dopaminergic neurons in the substantia nigra and ventral tegmental area that impact motor, reward and threat processing. We have identified GABAergic RMTg and RRF cell clusters in 6 μm formalin-fixed paraffin-embedded transverse human midbrain sections from ten control cases obtained from the Sydney Brain Bank using immunohistochemistry for GABA and tyrosine hydroxylase. We determined the location and cell size of RMTg and RRF GABAergic neurons, further mapping these cell clusters in transverse 50 μm thick cresyl violet stained serial midbrain sections (every 750 μm) from previously published controls (Halliday et al. 1990). GABAergic neurons were cytoarchitecturally distinct, with the largest GABAergic neurons in the RRF, followed by RMTg neurons which were larger than GABAergic neurons in the well-defined interpedunclular nucleus (Kruskal-Wallis test, p < 0.0001). RMTg and RRF GABAergic neurons first appear in caudal transverse midbrain sections approximately 38 mm above the obex. RMTg moves rostrally and medially from underneath the decussation of the superior cerebellar peduncle to just lateral to the interpeduncular nucleus. The RRF cluster also moves rostrally and medially to the parabrachial pigmented nucleus (PBP) just under the red nucleus. The GABAergic neurons in RMTg and RRF/PBP that modulate dopamine neuronal excitability have distinct morphologies in humans. Identifying these inhibitory neurons is key to evaluating their role in neurodegenerative diseases.

Supplementary Information: The online version contains supplementary material available at 10.1007/s00429-026-03103-x.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

• 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
• 0 scripts, each with its path and the digest of its content;
• no match between paragraphs and code yet;
• neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data availability

The data and analysis images, key lab materials and protocols used and generated in this study are listed in a Key Resource Table alongside their persistent identifiers at Zenodo DOI 10.5281/zenodo.17946370. No code was generated for this study; all data cleaning, preprocessing, analysis, and visualization was performed using VS200ASW ver. 4.1.1 build 29408 (https://evidentscientific.com/en/software).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

• Publisher: n/a → Springer Science+Business Media

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 6 keywords, 15 MeSH terms, 1 funder, 41 references, 8 RRIDs.

Cite

This paper

Filimontseva, A., Fu, Y., & Halliday, G. M. (2026). Location and mapping of the human rostromedial tegmental nucleus and associated midbrain inhibitory nuclei regulating dopamine neurons. Brain structure & function, 231(5), 64. https://doi.org/10.1007/s00429-026-03103-x

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1111/nan.70097

Transgenic A53T Mice Have Astrocytic α-Synuclein Aggregates in Dopamine and Striatal Regions.

Journal: Neuropathology and applied neurobiology

In common: 1 reference, author Glenda Halliday

[2] doi:10.1016/j.ebiom.2026.106400 [code]

Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.

Journal: EBioMedicine

In common: author Glenda Halliday

[3] doi:10.1038/s41467-026-74961-6 [code]

Spatial multi-omics identifies early synaptic pruning and context-specific dopaminergic vulnerability in synucleinopathies.

Journal: Nature communications

In common: 2 references

[4] doi:10.1038/s41467-026-73994-1 [code]

Prediction error correlates in the striosome-dopamine circuit emerge from information gain.

Journal: Nature communications

In common: 2 references

[5] doi:10.1073/pnas.2613593123 [code]

Calbindin stratifies midbrain dopaminergic neurons governing distinct aspects of locomotion.

Journal: Proceedings of the National Academy of Sciences of the United States of America

In common: 2 references

[6] doi:10.1016/j.celrep.2026.117298 [code]

Midbrain endocannabinoids actuate dopamine-based action selection.

Journal: Cell reports

In common: 2 references

[7] doi:10.7554/elife.93664 [code]

Drug-induced changes in connectivity to midbrain dopamine cells revealed by rabies monosynaptic tracing.

Journal: eLife

In common: 2 references

[8] doi:10.1016/j.isci.2026.117130 [code]

Region-specific weighting of sensory intensity and reward prediction error by dopamine signals.

Journal: iScience

In common: 2 references

[9] doi:10.1038/s41597-026-08133-y

A neuroimaging atlas of the nigrosomes in the substantia nigra based on 3D histology.

Journal: Scientific data

In common: histology / microscopy, 1 reference

[10] doi:10.1007/s00429-026-03146-0 [code]

Efferent projections of topographically distinct relaxin family peptide receptor-3 (RXFP3) lateral hypothalamus/zona incerta cells.

Journal: Brain structure & function

In common: 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.